Annual Accounts Receivable
N/A
31 December 2023
Summary:
GT Biopharma annual accounts receivable is not available.GTBP Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
N/A
30 September 2024
Summary:
GT Biopharma quarterly accounts receivable is not available.GTBP Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
GTBP Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
GT Biopharma Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | - | $0.00(-100.0%) |
| June 2014 | - | $5000.00(-83.3%) |
| Mar 2014 | - | $30.00 K(-25.0%) |
| Dec 2013 | $40.00 K(>+9900.0%) | $40.00 K(>+9900.0%) |
| Dec 2012 | $0.00(-100.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(-100.0%) |
| Sept 2009 | - | $14.00 K(+40.0%) |
| June 2009 | - | $10.00 K(+150.0%) |
| Mar 2009 | - | $4000.00(-98.2%) |
| Sept 2008 | - | $226.00 K(-15.4%) |
| June 2008 | - | $267.00 K(-69.8%) |
| Mar 2008 | - | $885.00 K(+6.6%) |
| Dec 2007 | $830.00 K(+13.4%) | $830.00 K(-0.2%) |
| Sept 2007 | - | $832.00 K(-26.1%) |
| June 2007 | - | $1.13 M(+37.3%) |
| Mar 2007 | - | $820.00 K(+12.0%) |
| Dec 2006 | $732.00 K(-15.4%) | $732.00 K(-18.1%) |
| Sept 2006 | - | $894.00 K(-3.9%) |
| June 2006 | - | $930.00 K(-7.2%) |
| Mar 2006 | - | $1.00 M(+15.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2005 | $865.00 K(+277.7%) | $865.00 K(+191.2%) |
| Sept 2005 | - | $297.00 K(+9.2%) |
| June 2005 | - | $272.00 K(-20.5%) |
| Mar 2005 | - | $342.00 K(+49.3%) |
| Dec 2004 | $229.00 K(-8.8%) | $229.00 K(-38.1%) |
| Sept 2004 | - | $370.00 K(+86.9%) |
| June 2004 | - | $198.00 K(-32.0%) |
| Mar 2004 | - | $291.00 K(+15.9%) |
| Dec 2003 | $251.00 K(+33.5%) | $251.00 K(-5.3%) |
| Sept 2003 | - | $265.00 K(+20.5%) |
| June 2003 | - | $220.00 K(-13.4%) |
| Mar 2003 | - | $254.00 K(+35.1%) |
| Dec 2002 | $188.00 K(+26.2%) | $188.00 K(-4.1%) |
| Sept 2002 | - | $196.00 K(+44.1%) |
| June 2002 | - | $136.00 K(-22.7%) |
| Mar 2002 | - | $176.00 K(+18.1%) |
| Dec 2001 | $149.00 K | $149.00 K(-5.7%) |
| Sept 2001 | - | $158.00 K(-55.4%) |
| June 2001 | - | $354.00 K(-6.6%) |
| Mar 2001 | - | $379.00 K |
FAQ
- What is the all time high annual accounts receivable for GT Biopharma?
- What is the all time high quarterly accounts receivable for GT Biopharma?
What is the all time high annual accounts receivable for GT Biopharma?
GT Biopharma all-time high annual accounts receivable is $865.00 K
What is the all time high quarterly accounts receivable for GT Biopharma?
GT Biopharma all-time high quarterly accounts receivable is $1.13 M